{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:13:19Z","timestamp":1777900399912,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gore.2025.101969","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:47:39Z","timestamp":1759999659000},"page":"101969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the socio-geographic and lifestyle factors impacting epithelial ovarian cancer outcomes: a retrospective study based on county health ranking in Missouri"],"prefix":"10.1016","volume":"62","author":[{"given":"Carlye","family":"Goldenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Krell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar Diaz","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooah","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Demirchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Anne","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Tuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-5920","authenticated-orcid":false,"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gore.2025.101969_b0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.gore.2025.101969_b0010","unstructured":"Cancer Stat Facts: Ovarian Cancer. National Institute of Health."},{"issue":"2","key":"10.1016\/j.gore.2025.101969_b0015","first-page":"93","article-title":"Epidemiology and risk factors for ovarian cancer","volume":"22","author":"Ali","year":"2023","journal-title":"Prz Menopauzalny."},{"key":"10.1016\/j.gore.2025.101969_b0020","doi-asserted-by":"crossref","unstructured":"Tavares V, Marques IS, Melo IG, Assis J, Pereira D, Medeiros R. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements. Int. J. Mol. Sci. Feb 3 2024;25(3) doi:10.3390\/ijms25031845.","DOI":"10.3390\/ijms25031845"},{"issue":"12","key":"10.1016\/j.gore.2025.101969_b0025","first-page":"1107","article-title":"The association between overweight, obesity and ovarian cancer: a meta-analysis","volume":"45","author":"Liu","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2025.101969_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2053369117709225","article-title":"Obesity and ovarian cancer risk: a systematic review","volume":"23","author":"Foong","year":"2017","journal-title":"Post Reprod. Health."},{"issue":"7","key":"10.1016\/j.gore.2025.101969_b0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/0284186X.2021.1919754","article-title":"Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study","volume":"60","author":"Toufakis","year":"2021","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.gore.2025.101969_b0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.33844","article-title":"Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes","volume":"150","author":"Sk\u00f6ld","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.gore.2025.101969_b0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.29271\/jcpsp.2021.06.651","article-title":"Initial Ca 125 Value as a Predictive Marker for high-grade Serous Ovarian Cancer","volume":"31","author":"Ay","year":"2021","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"2 Suppl","key":"10.1016\/j.gore.2025.101969_b0050","first-page":"524","article-title":"Ovarian cancer. Survival and treatment differences by age","volume":"71","author":"Ries","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.gore.2025.101969_b0055","doi-asserted-by":"crossref","unstructured":"Maioru OV, Radoi VE, Coman MC, et al. Developments in Genetics: Better Management of Ovarian Cancer Patients. Int. J. Mol. Sci. Nov 5 2023;24(21)doi:10.3390\/ijms242115987.","DOI":"10.3390\/ijms242115987"},{"key":"10.1016\/j.gore.2025.101969_b0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/bfm.2016.0113","article-title":"Why your ZIP code matters more than your genetic code: promoting healthy outcomes from mother to child","volume":"11","author":"Graham","year":"2016","journal-title":"Breastfeed. Med."},{"issue":"6","key":"10.1016\/j.gore.2025.101969_b0065","first-page":"542","article-title":"Ovarian Cancer Survival in Missouri, 1996-2014","volume":"115","author":"Yoshida","year":"2018","journal-title":"Mo Med. Nov-Dec"},{"issue":"4","key":"10.1016\/j.gore.2025.101969_b0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/PHH.0000000000000578","article-title":"Measuring Subcounty differences in Population Health using Hospital and Census-Derived Data Sets: the Missouri ZIP Health Rankings Project","volume":"24","author":"Nagasako","year":"2018","journal-title":"J Public Health Manag Pract. Jul\/aug"},{"key":"10.1016\/j.gore.2025.101969_b0075","unstructured":"County Health Rankings & Roadmaps. https:\/\/www.countyhealthrankings.org\/."},{"issue":"1","key":"10.1016\/j.gore.2025.101969_b0080","first-page":"8","article-title":"Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer","volume":"14","author":"Bachmann","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101969_b0085","doi-asserted-by":"crossref","unstructured":"Morales-V\u00e1squez F, Pedernera E, Reynaga-Obreg\u00f3n J, et al. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. J. Ovarian Res. Jul 7 2016;9(1):41. doi:10.1186\/s13048-016-0247-6.","DOI":"10.1186\/s13048-016-0247-6"},{"issue":"1","key":"10.1016\/j.gore.2025.101969_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/2193-1801-2-222","article-title":"Principled missing data methods for researchers","volume":"2","author":"Dong","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.gore.2025.101969_b0095","doi-asserted-by":"crossref","unstructured":"Hosmer D, Lemeshow S. Applied Logistic Regression. John Wiley & Sons, Inc.; 2000.","DOI":"10.1002\/0471722146"},{"issue":"15","key":"10.1016\/j.gore.2025.101969_b0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2025.101969_b0105","doi-asserted-by":"crossref","unstructured":"S\u00f6l\u00e9tormos G, Duffy MJ, Othman Abu Hassan S, et al. Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers. Int. J. Gynecol. Cancer. Jan 2016;26(1):43-51. doi: 10.1097\/igc.0000000000000586.","DOI":"10.1097\/IGC.0000000000000586"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:31:13Z","timestamp":1777631473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"alternative-id":["S2352578925002942"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101969","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the socio-geographic and lifestyle factors impacting epithelial ovarian cancer outcomes: a retrospective study based on county health ranking in Missouri","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101969"}}